Streetbeat News

Analyst Ratings

MKSI

MKS Instruments (NASDAQ:MKSI) received varied analyst ratings, with a recent shift towards more bullish views. The average 12-month price target was raised to $128.75, up 23.8% from $104.00, reflecting positive adjustments by analysts from Keybanc, Benchmark, and Needham. Despite this optimism, MKS Instruments faces challenges in market capitalization, revenue growth, net margin, ROE, ROA, and debt management, indicating potential financial difficulties.

Portfolio Pulse from Benzinga Insights

February 09, 2024 | 8:00 pm

BAX

JP Morgan analyst Robbie Marcus maintains a Neutral rating on Baxter International (BAX) and raises the price target from $38 to $44.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 7:58 pm

AXTA

JP Morgan analyst Jeffrey Zekauskas has maintained an Overweight rating on Axalta Coating Systems (AXTA) and increased the price target from $35 to $38.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 7:53 pm

ARES

JP Morgan analyst Kenneth Worthington maintains an Overweight rating on Ares Management (NYSE:ARES) and raises the price target from $119 to $141.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 7:52 pm

BMY

Bristol-Myers Squibb (NYSE:BMY) has seen significant options trading activity, with a bullish sentiment from big-money traders. The trading volume and open interest suggest a focus on a price band between $45.0 and $60.0. Recent trades include both puts and calls, with a notable split in sentiment. Analysts have set an average target price of $52.5, with mixed ratings from Wells Fargo and Redburn Atlantic. The company's stock is currently neutral with a slight increase in price.

Portfolio Pulse from Benzinga Insights

February 09, 2024 | 7:45 pm

AFRM

JP Morgan analyst Reginald Smith maintains a Neutral rating on Affirm Holdings (NASDAQ:AFRM) and raises the price target from $35 to $41.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 7:42 pm

MKSI

Keybanc analyst Steve Barger maintains an Overweight rating on MKS Instruments (MKSI) and raises the price target from $115 to $140.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 7:40 pm

OSCR

Oscar Health's stock price increased following Goldman Sachs' decision to maintain a Neutral rating on the stock while raising its price target from $8 to $16.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 7:39 pm

PI

Roth MKM analyst Scott Searle maintains a Buy rating on Impinj (NASDAQ:PI) and raises the price target from $95 to $115, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 7:39 pm

PRDO

Barrington Research analyst Alexander Paris has reiterated an Outperform rating on Perdoceo Education (NASDAQ:PRDO) and maintained a $23 price target.

Portfolio Pulse from Benzinga Newsdesk

February 09, 2024 | 7:37 pm